Project ACT is our game plan to make cell therapies a reality for millions around the world who live with type 1 diabetes.| Breakthrough T1D
The recipient of gene-edited islets to evade the immune system is making insulin without the use of immunusuppresives.| Breakthrough T1D
Breakthrough T1D was in Chicago, IL for ADA 2025. Here we report on the latest advancements in cures for type 1 diabetes.| Breakthrough T1D
Type 1 diabetes cell therapies safely replace the beta cells that the autoimmune system destroys to allow the body to produce insulin again.| Breakthrough T1D
Data Demonstrate that Sana’s Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Persist and Function Over Time in Patient with Type 1 Diabetes Study Establishes Ability to Genetically Modify and Transplant Pancreatic Islet Cells Without Immunosuppression and| Sana Biotechnology, Inc